genentech inc. said 0 the west german distributor of its heart drug tpa reached a joint marketing agreement with a subsidiary of hoechst ag , which makes the rival anti-clotting agent streptokinase . the biotechnology concern said 0 the agreement between its longtime west german distributor , boehringer-ingleheim 's dr. karl thomae g.m.b.h. subsidiary , and hoechst 's behringwerke subsidiary was an attempt to expand the market for blood-clot drugs in general . a genentech spokeswoman said 0 the agreement calls for hoechst to promote tpa for heart patients and streptokinase for other clot-reducing purposes .